Specifically, in breast cancer, ZKSCAN3 expression exhibits a positive correlation with CCND1 and BCL2 expression, while it negatively correlates with the expression of Bcl2 Associated X Protein (Bax). This evidence concerns the gene BCL2 and breast carcinoma.